192 related articles for article (PubMed ID: 17241110)
1. Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation.
Moser B; Szabolcs MJ; Ankersmit HJ; Lu Y; Qu W; Weinberg A; Herold KC; Schmidt AM
Am J Transplant; 2007 Feb; 7(2):293-302. PubMed ID: 17241110
[TBL] [Abstract][Full Text] [Related]
2. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings.
Stern D; Yan SD; Yan SF; Schmidt AM
Adv Drug Deliv Rev; 2002 Dec; 54(12):1615-25. PubMed ID: 12453678
[TBL] [Abstract][Full Text] [Related]
3. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection.
Metzler B; Gfeller P; Bigaud M; Li J; Wieczorek G; Heusser C; Lake P; Katopodis A
J Immunol; 2004 Dec; 173(11):7025-36. PubMed ID: 15557200
[TBL] [Abstract][Full Text] [Related]
4. The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease.
Yan SF; Ramasamy R; Schmidt AM
Expert Rev Mol Med; 2009 Mar; 11():e9. PubMed ID: 19278572
[TBL] [Abstract][Full Text] [Related]
5. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.
Stern DM; Yan SD; Yan SF; Schmidt AM
Ageing Res Rev; 2002 Feb; 1(1):1-15. PubMed ID: 12039445
[TBL] [Abstract][Full Text] [Related]
6. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.
Riuzzi F; Sorci G; Donato R
J Biol Chem; 2006 Mar; 281(12):8242-53. PubMed ID: 16407300
[TBL] [Abstract][Full Text] [Related]
7. RAGE ligation affects T cell activation and controls T cell differentiation.
Chen Y; Akirav EM; Chen W; Henegariu O; Moser B; Desai D; Shen JM; Webster JC; Andrews RC; Mjalli AM; Rothlein R; Schmidt AM; Clynes R; Herold KC
J Immunol; 2008 Sep; 181(6):4272-8. PubMed ID: 18768885
[TBL] [Abstract][Full Text] [Related]
8. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation.
Huttunen HJ; Kuja-Panula J; Sorci G; Agneletti AL; Donato R; Rauvala H
J Biol Chem; 2000 Dec; 275(51):40096-105. PubMed ID: 11007787
[TBL] [Abstract][Full Text] [Related]
9. PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection.
Tanaka K; Albin MJ; Yuan X; Yamaura K; Habicht A; Murayama T; Grimm M; Waaga AM; Ueno T; Padera RF; Yagita H; Azuma M; Shin T; Blazar BR; Rothstein DM; Sayegh MH; Najafian N
J Immunol; 2007 Oct; 179(8):5204-10. PubMed ID: 17911605
[TBL] [Abstract][Full Text] [Related]
10. Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic disease.
Schmidt AM; Stern DM
Front Biosci; 2001 Oct; 6():D1151-60. PubMed ID: 11578972
[TBL] [Abstract][Full Text] [Related]
11. The biology of the receptor for advanced glycation end products and its ligands.
Schmidt AM; Yan SD; Yan SF; Stern DM
Biochim Biophys Acta; 2000 Dec; 1498(2-3):99-111. PubMed ID: 11108954
[TBL] [Abstract][Full Text] [Related]
12. Impaired NF-kappaB activation in T cells permits tolerance to primary heart allografts and to secondary donor skin grafts.
Zhou P; Hwang KW; Palucki DA; Guo Z; Boothby M; Newell KA; Alegre ML
Am J Transplant; 2003 Feb; 3(2):139-47. PubMed ID: 12603209
[TBL] [Abstract][Full Text] [Related]
13. RAGE and the pathogenesis of chronic kidney disease.
D'Agati V; Schmidt AM
Nat Rev Nephrol; 2010 Jun; 6(6):352-60. PubMed ID: 20421886
[TBL] [Abstract][Full Text] [Related]
14. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.
Taguchi A; Blood DC; del Toro G; Canet A; Lee DC; Qu W; Tanji N; Lu Y; Lalla E; Fu C; Hofmann MA; Kislinger T; Ingram M; Lu A; Tanaka H; Hori O; Ogawa S; Stern DM; Schmidt AM
Nature; 2000 May; 405(6784):354-60. PubMed ID: 10830965
[TBL] [Abstract][Full Text] [Related]
15. Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.
Basta G
Atherosclerosis; 2008 Jan; 196(1):9-21. PubMed ID: 17826783
[TBL] [Abstract][Full Text] [Related]
16. RAGE: a multi-ligand receptor unveiling novel insights in health and disease.
Alexiou P; Chatzopoulou M; Pegklidou K; Demopoulos VJ
Curr Med Chem; 2010; 17(21):2232-52. PubMed ID: 20459381
[TBL] [Abstract][Full Text] [Related]
17. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.
Yan SF; Ramasamy R; Schmidt AM
J Mol Med (Berl); 2009 Mar; 87(3):235-47. PubMed ID: 19189073
[TBL] [Abstract][Full Text] [Related]
18. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system.
Hori O; Brett J; Slattery T; Cao R; Zhang J; Chen JX; Nagashima M; Lundh ER; Vijay S; Nitecki D
J Biol Chem; 1995 Oct; 270(43):25752-61. PubMed ID: 7592757
[TBL] [Abstract][Full Text] [Related]
19. RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice.
Juranek JK; Geddis MS; Song F; Zhang J; Garcia J; Rosario R; Yan SF; Brannagan TH; Schmidt AM
Diabetes; 2013 Mar; 62(3):931-43. PubMed ID: 23172920
[TBL] [Abstract][Full Text] [Related]
20. Induction of CD4+CD25+ T cells and control of cardiac allograft rejection by CD40/CD40L costimulatory pathway blockade in mice.
Fu W; Zhu J; Qiu Y; Li W
Transplant Proc; 2013 Mar; 45(2):611-7. PubMed ID: 23498798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
